Adheris Health Limited
AASX:AHE0.01
AUD
0.00
(0.00%)
Adheris Health Limited
ASX:AHE
(Australian Securities Exchange)
Recent
price
0.01
P/E
ratio
345.98
div
yld
- -
ROIC.AI
Capital Structure
AUD
•
in mil. unless spec.Working Capital
AUD
•
in mil. unless spec.Growth Rates
AUD
•
in mil. unless spec.Semi-annual Revenue
AUD
•
in mil. unless spec.Semi-annual Earnings Per Share
AUD
•
in mil. unless spec.Semi-annual Dividends Per Share
AUD
•
in mil. unless spec.- Similar Companies
- Business
- Adheris Health Limited is a pharmaceutical and healthcare information technology company that specializes in pharmacy‑driven patient engagement solutions. Through its THRiV platform, the company delivers an omnichannel suite that combines patient and prescriber engagement, AI‑enabled analytics, and workflow enhancements designed to improve medication adherence and outcomes. Headquartered in Australia and listed on the ASX (ticker: AHE.AX), Adheris Health operates across multiple regions including Australia, the United States, and the United Kingdom, leveraging its technology to support community and retail pharmacy networks, clinics, and health systems. The firm focuses on enabling personalized patient journeys, optimizing pharmacy operations, and expanding access to digital engagement tools for diverse therapeutic areas. Founding year and corporate structure Adheris Health traces its origins to MedAdvisor Limited and adopts its current brand as part of a broader corporate realignment in late 2025, consolidating its focus on pharmacy‑driven patient engagement solutions under a refined leadership and strategic realignment program. The company maintains a multi‑jurisdictional footprint and operates through its subsidiary network to serve pharmacy chains, independent pharmacies, and healthcare providers in its target markets. Main products and services - THRiV platform: cloud‑based, AI‑enabled patient engagement and prescriber engagement system; omnichannel communications; patient journey personalization and real‑time analytics - Pharmacy workflow optimization tools: digital engagement workflows for dispensing, adherence monitoring, and patient outreach; integration with pharmacy management systems and electronic health records - Patient engagement services: personalized patient education, reminders, adherence supports, and telehealth or virtual care coordination - Data and analytics services: predictive analytics for adherence risk, population health insights, and ROI reporting for payer and provider programs - Therapeutic area modules: solutions tailored to chronic disease management, vaccination programs, and high‑growth therapeutic segments - Channel offerings: digital channels (mobile, web), mail and direct outreach, and in‑pharmacy engagement tools to support the complete medication journey Recent major changes and strategic initiatives - Strategic realignment and leadership refresh: appointment of a new leadership team as part of a broader operational realignment to reduce reliance on vaccine programs and broaden revenue streams - New technology platform launch: December 2025 introduction of an enhanced omnichannel platform designed to improve delivery efficiency and user experience - Cost optimization program: accelerated cost‑out initiative targeting substantial operating expense reductions over FY25–FY27 to support profitability and resilience - Expanded market reach and product scope: efforts to broaden the pharmacy network, diversify into higher‑margin solutions, and enhance digital engagement capabilities across regions - Focused growth in high‑growth therapeutic areas: strategic shift toward therapies with stronger growth trajectories and payer/partner demand, reducing exposure to less‑profitable or volatile segments - Governance and reporting transitions: enhanced governance and transparency in reporting with a renewed management team to support scalable growth and execution of strategic initiatives Industry context and business segments - Sector: healthcare information technology and pharmaceutical services - Primary segments: pharmacy‑driven patient engagement; digital health workflows; omnichannel patient and prescriber communications; clinical and outcomes analytics - Target customers: community and chain pharmacies, independent pharmacies, healthcare providers, and health plans seeking improved adherence and efficiency - Geographic footprint: Australia, United States, United Kingdom, and select international markets through partner networks Subsidiaries and corporate relationships - Operates under a parent company structure with regional subsidiaries to support multi‑jurisdictional delivery of THRiV and related services - Positioned as a technology and services provider within the broader Adheris Health ecosystem, integrating with partner health systems and pharmacy networks to scale engagement programs Notes - The company trades under the ASX ticker AHE.AX and is recognized for its focus on transforming the patient medication experience through digital engagement, analytics, and optimized pharmacy workflows. The latest corporate developments reflect a strategic pivot toward diversified revenue, higher‑margin offerings, and an expanded global footprint.